BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
BioLineRx priced a $3.75 million registered direct offering and concurrent private placement, selling approximately 1.35 million ADSs at $2.78 per share. The transaction includes warrants to purchase up to 2.02 million ADSs and an amendment to existing warrants covering 277,273 ADSs, which lowers the exercise price to $2.78 and extends the expiration date to August 31, 2031.
Key figures
- Deal Value Usd
- 3750000
- Offering Price
- 2.78
- Shares Offered
- 1348921
- Warrants offered
- 2023382
- Warrant amended shares
- 277273
- Warrant exercise price
- 2.78
- Warrant amended expiration
- August 31, 2031
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.